Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 USD | -0.29% | -8.66% | +64.93% |
May. 03 | Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating | MT |
May. 02 | Geron Shares Decline After Q1 Loss Widens | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
2.07B | - | |||||
116B | ||||||
106B | ||||||
23.89B | - | |||||
21.58B | - | |||||
18.96B |
- Stock Market
- Equities
- GERN Stock
- Charts Geron Corporation
- Sector Chart